Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma

por MAHGOUB, T., EUSTACE, A.J., COLLINS, D.M., WALSH, N., O'DONOVAN, N., CROWN, J.
Publicado 2015

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer

por Ryan, B, O'Donovan, N, Browne, B, O'Shea, C, Crown, J, Hill, A D K, McDermott, E, O'Higgins, N, Duffy, M J
Publicado 2005

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells

por Caiazza, F, McGowan, P M, Mullooly, M, Murray, A, Synnott, N, O'Donovan, N, Flanagan, L, Tape, C J, Murphy, G, Crown, J, Duffy, M J
Publicado 2015

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer

por Eustace, A. J., Madden, S. F., Fay, J., Collins, D. M., Kay, E. W., Sheehan, K. M., Furney, S., Moran, B., Fagan, A., Morris, P. G., Teiserskiene, A., Hill, A. D., Grogan, L., Walshe, J. M., Breathnach, O., Power, C., Duke, D., Egan, K., Gallagher, W. M., O’Donovan, N., Crown, J., Toomey, S., Hennessy, B. T.
Publicado 2021